We found that while rhTRAIL downregulated the mRNA levels of TRAIL receptors TNFRSF10A and TNFRSF10B, MSC-sTRAIL treatment had little effects on the expression levels of TRAIL receptors of B-ALL cells (Supplementary Figure S4). Here, TNFRSF10B is linked to acute lymphoblastic leukemia.